HULME ALLISON 4/A
4/A · Ventyx Biosciences, Inc. · Filed Apr 26, 2023
Insider Transaction Report
Form 4/AAmended
HULME ALLISON
Director
Transactions
- Award
Stock Option (right to buy)
2023-01-11+20,427→ 20,427 totalExercise: $34.16Exp: 2033-01-11→ Common Stock (20,427 underlying)
Footnotes (2)
- [F1]The Form 4 filed on January 12, 2023, erroneously reported that reporting person received an option award for 12,880 shares on January 11, 2023. The correct option award amount is for 20,427 shares.
- [F2]One-thirty sixth (1/36th) of the Shares subject to the option will be scheduled to vest each month following the grant date, in each case subject to the reporting person continuing to be a Service Provider (as defined in the Company's 2021 Equity Incentive Plan) through the applicable vesting date.